Aprepitant
NDC 68462-585, Aprepitant, capsule, from Glenmark Pharmaceuticals Inc., USA.
- Product NDC
- 68462-585
- Status
- Listed
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207777
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68462-585 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- APREPITANT125 mg/1
Pharmacologic classes
Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]; Substance P/Neurokinin-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68462-585-76 | 68462058576 | 1 BLISTER PACK in 1 CARTON (68462-585-76) / 6 CAPSULE in 1 BLISTER PACK (68462-585-40) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d72e0e10-4557-41b0-b65d-d395468cad19Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=68462-585NADAC price for package 68462058576
GET /v1/drugs/nadac/68462058576
Use it
Look up 68462-585 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68462-585 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68462-585. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.